Tumor Immunology 101 Program Schedule

An Affiliate Program of the SITC ACI™ Series, held prior to the 2014 ASCO Annual Meeting

Friday, May 30, 2014
Prairie Room
Hyatt Conference Center
Hyatt Regency McCormick Place
2233 S. Martin L. King Drive
Chicago, IL 60616

Program Schedule

Presentations included allotted time for Audience Response System (ARS) assisted audience
interaction as well as general question and answer time.

To view PDF slides of the presentations, click on the icon.

7:00 am – 8:00 am	Registration
7:00 am – 8:00 am	Breakfast
Welcome and Overview: Understanding the Immune System .5 AMA PRA Category 1 Credit™
8:00 am – 8:05 am	Welcome and Overview Mary L. Disis, MD, FACP - University of Washington
8:05 am – 8:30 am	The Basics of the Immune System: Our Friends and Foes   Mary L. Disis, MD, FACP - University of Washington
SESSION I: Immuno-Basics for Combating Cancer 1.5 AMA PRA Category 1 Credit™
8:30 am – 8:55 am	T-Cells: How do they Work and How Can We Use Them to Combat Cancer?   Jeffrey S. Weber, MD, PhD – Moffitt Cancer Center
8:55 am – 9:20 am	B-Cells: How do they Work and How Can We Use Them to Combat Cancer?   Edmund K. Waller, MD, PhD, FACP – Emory University
9:20 am – 9:45 am	What is Innate Immunity and How Does It Work to Combat Cancer?   Justin P. Kline, MD - University of Chicago
9:45 am – 10:05 am	Panel Discussion
10:05 am – 10:20 am	Break
SESSION II: Standard Cancer Treatments and the Immuno-Influence 1.75 AMA PRA Category 1 Credit™
10:20 am – 10:45 am	Is There a Role for Combining Chemotherapy and Immunotherapy?   Leisha A. Emens, MD, PhD – Johns Hopkins University
10:45 am – 11:10 am	Is There a Role for Combining Radiation Therapy and Immunotherapy?   Sandra Demaria, MD – New York University
11:10 am – 11:35 am	Combination Immunotherapy: Can 1 + 1 Equal 4?   Howard L. Kaufman, MD, FACS – Rutgers Cancer Institute of New Jersey
11:35 am – 11:55 am	Panel Discussion
11:55 am – 12:00 pm	Closing Comments Howard L. Kaufman, MD, FACS – Rutgers Cancer Institute of New Jersey

All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.